Neoadjuvant chemotherapy in localized resectable stomach cancer
In localized resectable stage II or III gastric cancer, D2 dissection has been accepted as the standard surgical method worldwide. The Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer and Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer phase III trials have demonstrated that syst...
| Published in: | Korean Journal of Clinical Oncology |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Korean Society of Surgical Oncology
2014-06-01
|
| Subjects: | |
| Online Access: | http://www.kjco.org/upload/kjco-10-1-1.pdf |